{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:25:37Z","timestamp":1784168737036,"version":"3.55.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54DA036114"],"award-info":[{"award-number":["U54DA036114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01CA189300"],"award-info":[{"award-number":["K01CA189300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R36DA045183"],"award-info":[{"award-number":["R36DA045183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The US Food and Drug Administration is considering implementing a reduced-nicotine standard for cigarettes. Given the high rate of smoking among people with serious mental illness (SMI), it is important to examine the responses of these smokers to very low nicotine content (VLNC) cigarettes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This trial compared the effects of VLNC (0.4 mg nicotine\/g tobacco) and normal nicotine content cigarettes (15.8 mg\/g) over a 6-week period in non-treatment-seeking smokers with schizophrenia, schizoaffective disorder, or bipolar disorder (n = 58). Linear regression was used to examine the effects of cigarette condition on cigarettes per day, subjective responses, nicotine and tobacco toxicant exposure, craving, withdrawal symptoms, and psychiatric symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At week 6, participants in the VLNC condition smoked fewer cigarettes per day, had lower breath carbon monoxide levels, lower craving scores, and rated their study cigarettes lower in satisfaction, reward, enjoyment, and craving reduction than those in the normal nicotine content condition (ps &amp;lt; .05). Week 6 psychiatric and extrapyramidal symptoms did not differ by condition, except for scores on a measure of parkinsonism, which were lower in the VLNC condition (p &amp;lt; .05). There were no differences across conditions on total nicotine exposure, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, withdrawal symptoms, or responses to abstinence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results suggest that a reduced-nicotine standard for cigarettes would reduce smoking among smokers with SMI. However, the lack of effect on total nicotine exposure indicates VLNC noncompliance, suggesting that smokers with SMI may respond to a reduced-nicotine standard by substituting alternative forms of nicotine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>Results from this trial suggest that a reduced-nicotine standard for cigarettes would reduce smoking rates and smoke exposure in smokers with SMI, without increasing psychiatric symptoms. However, noncompliance with VLNC cigarettes was observed, suggesting that these smokers might respond to a reduced-nicotine standard by substituting alternative forms of nicotine.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/ntz133","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T19:13:22Z","timestamp":1566069202000},"page":"S38-S45","source":"Crossref","is-referenced-by-count":35,"title":["Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness"],"prefix":"10.1093","volume":"21","author":[{"given":"Jennifer W","family":"Tidey","sequence":"first","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2027-5936","authenticated-orcid":false,"given":"Suzanne M","family":"Colby","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"Denlinger-Apte","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Goodwin","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Cioe","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N","family":"Cassidy","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Swift","sequence":"additional","affiliation":[{"name":"Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R","family":"Lindgren","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Rubin","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E","family":"Murphy","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-1356","authenticated-orcid":false,"given":"Stephen S","family":"Hecht","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy K","family":"Hatsukami","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3288-9652","authenticated-orcid":false,"given":"Eric C","family":"Donny","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"issue":"12","key":"2020122215392585300_CIT0001","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2105\/AJPH.2009.188136","article-title":"Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey","volume":"100","author":"McClave","year":"2010","journal-title":"Am J Public Health."},{"issue":"1","key":"2020122215392585300_CIT0002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychires.2013.09.014","article-title":"Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression","volume":"48","author":"Callaghan","year":"2014","journal-title":"J Psychiatr Res."},{"key":"2020122215392585300_CIT0003","doi-asserted-by":"crossref","first-page":"h4065","DOI":"10.1136\/bmj.h4065","article-title":"Smoking cessation and reduction in people with chronic mental illness","volume":"351","author":"Tidey","year":"2015","journal-title":"BMJ."},{"issue":"2","key":"2020122215392585300_CIT0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/JCP.0000000000001015","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES Trial","volume":"39","author":"Evins","year":"2019","journal-title":"J Clin Psychopharmacol."},{"key":"2020122215392585300_CIT0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-publhealth-031816-044618","article-title":"Smoking, mental illness, and public health","volume":"38","author":"Prochaska","year":"2017","journal-title":"Annu Rev Public Health."},{"key":"2020122215392585300_CIT0006","article-title":"Statement of FDA Commission Scott Gottlieb, M.D., on pivotal public health step to dramatically reduce smoking rates by lowering nicotine in combustible cigarettes to minimally or non-addictive levels.","author":"Food and Drug Administration"},{"key":"2020122215392585300_CIT0007","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1136\/tobaccocontrol-2012-050860","article-title":"Reducing the nicotine content to make cigarettes less addictive","volume":"22","author":"Benowitz","year":"2013","journal-title":"Tob Control"},{"issue":"5","key":"2020122215392585300_CIT0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/1055-9965.EPI-11-0644","article-title":"Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes","volume":"21","author":"Benowitz","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"14","key":"2020122215392585300_CIT0009","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMsa1502403","article-title":"Randomized trial of reduced-nicotine standards for cigarettes","volume":"373","author":"Donny","year":"2015","journal-title":"N Engl J Med."},{"issue":"9","key":"2020122215392585300_CIT0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2018.11473","article-title":"Effect of immediate vs gradual reduction in nicotine content of cigarettes on biomarkers of smoke exposure: a randomized clinical trial","volume":"320","author":"Hatsukami","year":"2018","journal-title":"JAMA."},{"issue":"10","key":"2020122215392585300_CIT0011","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jamapsychiatry.2018.1831","article-title":"Nondaily smokers\u2019 changes in cigarette consumption with very low-nicotine-content cigarettes: a randomized double-blind clinical trial","volume":"75","author":"Shiffman","year":"2018","journal-title":"JAMA Psychiatry."},{"issue":"12","key":"2020122215392585300_CIT0012","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/add.13519","article-title":"Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes","volume":"111","author":"Nardone","year":"2016","journal-title":"Addiction."},{"issue":"10","key":"2020122215392585300_CIT0013","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamapsychiatry.2017.2355","article-title":"Addiction potential of cigarettes with reduced nicotine content in populations with psychiatric disorders and other vulnerabilities to tobacco addiction","volume":"74","author":"Higgins","year":"2017","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"2020122215392585300_CIT0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ntr\/nts098","article-title":"Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls","volume":"15","author":"Tidey","year":"2013","journal-title":"Nicotine Tob Res."},{"issue":"9","key":"2020122215392585300_CIT0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/ntr\/ntw089","article-title":"Smoking topography characteristics of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls","volume":"18","author":"Tidey","year":"2016","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2020122215392585300_CIT0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ntr\/ntw199","article-title":"Effects of 6-week use of reduced-nicotine content cigarettes in smokers with and without elevated depressive symptoms","volume":"19","author":"Tidey","year":"2017","journal-title":"Nicotine Tob Res."},{"key":"2020122215392585300_CIT0017","volume-title":"Structured Clinical Interview for DSM-IV Axis-I Disorders\u2014Patient Edition (SCID -I \/ P, Version 2.0)","author":"First","year":"1994"},{"issue":"1","key":"2020122215392585300_CIT0018","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1037\/0021-843X.115.1.166","article-title":"Experimental evidence for a causal relationship between smoking lapse and relapse","volume":"115","author":"Juliano","year":"2006","journal-title":"J Abnorm Psychol."},{"key":"2020122215392585300_CIT0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","article-title":"Timeline follow-back: a technique for assessing self-reported ethanol consumption","volume-title":"Measuring Alcohol Consumption: Psychosocial and Biological Methods","author":"Sobell","year":"1992"},{"issue":"2","key":"2020122215392585300_CIT0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yrtph.2006.09.001","article-title":"Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany","volume":"47","author":"Scherer","year":"2007","journal-title":"Regul Toxicol Pharmacol."},{"issue":"9","key":"2020122215392585300_CIT0021","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict."},{"issue":"1","key":"2020122215392585300_CIT0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","article-title":"Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings","volume":"3","author":"Cox","year":"2001","journal-title":"Nicotine Tob Res."},{"issue":"3","key":"2020122215392585300_CIT0023","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry."},{"issue":"5","key":"2020122215392585300_CIT0024","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.addbeh.2006.06.028","article-title":"Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire","volume":"32","author":"Cappelleri","year":"2007","journal-title":"Addict Behav."},{"issue":"6","key":"2020122215392585300_CIT0025","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J Pers Soc Psychol."},{"issue":"2","key":"2020122215392585300_CIT0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"issue":"S7","key":"2020122215392585300_CIT0027","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","article-title":"The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations","author":"Andreasen","year":"1989","journal-title":"Br J Psychiatry"},{"issue":"3","key":"2020122215392585300_CIT0028","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"key":"2020122215392585300_CIT0029","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the calgary depression scale","volume":"22","author":"Addington","year":"1993","journal-title":"Br J Psychiatry Suppl"},{"issue":"3","key":"2020122215392585300_CIT0030","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"2020122215392585300_CIT0031","volume-title":"Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology, 1976","author":"National Institute of Mental Health (NIMH)"},{"key":"2020122215392585300_CIT0032","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"45(S212)","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl."},{"key":"2020122215392585300_CIT0033","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry."},{"issue":"3","key":"2020122215392585300_CIT0034","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(02)00324-X","article-title":"Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia","volume":"27","author":"Smith","year":"2002","journal-title":"Neuropsychopharmacology."},{"issue":"2\u20133","key":"2020122215392585300_CIT0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.schres.2009.09.032","article-title":"Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls","volume":"115","author":"Tidey","year":"2009","journal-title":"Schizophr Res."},{"issue":"6","key":"2020122215392585300_CIT0036","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","article-title":"Drug interactions with tobacco smoking. An update","volume":"36","author":"Zevin","year":"1999","journal-title":"Clin Pharmacokinet."},{"issue":"2","key":"2020122215392585300_CIT0037","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/HRP.0000000000000063","article-title":"Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices","volume":"23","author":"Evins","year":"2015","journal-title":"Harv Rev Psychiatry."},{"issue":"3","key":"2020122215392585300_CIT0038","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1037\/1064-1297.8.3.366","article-title":"The influence of exchange delays on cigarette versus money choice: a laboratory analog of voucher-based reinforcement therapy","volume":"8","author":"Roll","year":"2000","journal-title":"Exp Clin Psychopharmacol."},{"issue":"2","key":"2020122215392585300_CIT0039","doi-asserted-by":"crossref","first-page":"186","DOI":"10.18001\/TRS.2.2.9","article-title":"Nicotine and anatabine exposure from very low nicotine content cigarettes","volume":"2","author":"Denlinger","year":"2016","journal-title":"Tob Regul Sci."},{"issue":"5","key":"2020122215392585300_CIT0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ntr\/ntu163","article-title":"Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls","volume":"17","author":"AhnAllen","year":"2015","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2020122215392585300_CIT0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12971-015-0030-2","article-title":"E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial","volume":"13","author":"O\u2019Brien","year":"2015","journal-title":"Tob Induc Dis."},{"issue":"11","key":"2020122215392585300_CIT0042","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13111166","article-title":"Views and preferences for nicotine products as an alternative to smoking: a focus group study of people living with mental disorders","volume":"13","author":"Meurk","year":"2016","journal-title":"Int J Environ Res Public Health"}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/21\/Supplement_1\/S38\/35065097\/ntz133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/21\/Supplement_1\/S38\/35065097\/ntz133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T20:40:02Z","timestamp":1608669602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/21\/Supplement_1\/S38\/5684952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":42,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,12,23]]},"published-print":{"date-parts":[[2019,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntz133","relation":{},"ISSN":["1462-2203","1469-994X"],"issn-type":[{"value":"1462-2203","type":"print"},{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,12]]}}}